Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Cash generated from core business operations
Latest
$-189.55M
↓ 15% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-164.27M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-189.55M | +58.4% |
| 2024 | $-455.57M | -40.5% |
| 2023 | $-324.23M | -44.2% |
| 2022 | $-224.86M | -22.3% |
| 2021 | $-183.92M | -16.7% |
| 2020 | $-157.56M | -278.5% |
| 2019 | $-41.62M | -63.2% |
| 2018 | $-25.51M | -14.3% |
| 2017 | $-22.32M | -26.7% |
| 2016 | $-17.61M | - |